Life Molecular Imaging – Website

Innovative PET imaging agents for earlier and improved diagnosis and better characterization of diseases

Search Icon

Menu Toggle Icon

Skip to content
  • Home
  • About us
    • Leadership Team
    • Partners
    • Business Development & Licensing
    • Compliance & Code of Conduct
    • Contacts
  • Molecular Imaging
    • How It Works
    • Value of Molecular Imaging
  • Research & Development
    • Neuro-Imaging
    • Onco-Imaging
    • Cardiovascular-Imaging
  • Products
  • News
    • Current News
    • Careers

Life Molecular Imaging Announces Presentation of New Clinical Data of the Next Generation Tau PET Tracer PI-2620 at the AD/PD 2019 Conference

27. Mar 201927. Mar 2019lifemolecular

Readmore: New clinical data of PI-2620 Tau-PET highlight the sensitive detection of Tau pathology in neurodegenerative diseases .

Related

Post navigation

← Life Molecular Imaging and XingImaging Announce PI-2620 Tau PET Tracer Production in Mainland China
Life Molecular Imaging Applauds the Publication of the IDEAS Study Aim I Results →
© Copyright 2018 Life Molecular Imaging
Imprint / Data protection
Contact
Scroll to Top
Data Protection & Cookies. Our site uses cookies.
Click here to learn more: Data protection